Evidence map›Paper›PMID 42028410›Full record

ArticlePatterns (New York, N.Y.)2026

Modeling of longitudinal immune profiles reveals distinct immunogenic signatures following five COVID-19 vaccinations among people living with HIV.

Chapin S Korosec, Jessica M Conway, Vitaliy A Matveev, Mario Ostrowski, Jane M Heffernan, Mohammad Sajjad Ghaemi

Abstract read
In one paragraph

Article in Patterns (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chapin S KorosecDepartment of Mathematics and Statistics, University of Guelph, Guelph, ON, Canada.
Jessica M ConwayDepartment of Mathematics, Pennsylvania State University, University Park, PA, USA.
Vitaliy A MatveevDepartment of Medicine, University of Toronto, Toronto, ON, Canada.
Mario OstrowskiDepartment of Medicine, University of Toronto, Toronto, ON, Canada.
Jane M HeffernanModelling Infection and Immunity Lab, Mathematics and Statistics, York University, Toronto, ON, Canada.
Mohammad Sajjad GhaemiDigital Technologies Research Centre, National Research Council Canada, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immune response to vaccination is highly heterogeneous and arises from a dynamic interplay of immune components. Harnessing machine learning (ML) to learn immune interdependencies offers the potential not only to decode immune signatures linked to a specified comorbidity but also to reveal individualized patterns laying the groundwork for precision-guided vaccination and targeted clinical follow-up. We employ a random forest (RF) approach to classify informative differences in immunogenicity between older people living with HIV (PLWH) on antiretroviral therapy (ART) and an age-matched control group who received up to five SARS-CoV-2 vaccinations. RFs identify evidence for T helper 1 (Th1) imprinting and reveal novel distinguishing immune features, such as saliva-based antibody screening, as promising diagnostic tools (whereas serum IgG is not). Our modeling approach reveals a subset of PLWH whose immune signatures are indistinguishable from the HIV- control group, which we interpret as near-complete immune restoration from a longitudinal vaccine-elicited immunogenic perspective. To expand the utility of our findings, we generate privacy-preserving synthetic "virtual patients" that accurately approximate the original longitudinal immunologic data and show, via train-on-synthetic/test-on-real evaluation, that RF classifiers trained solely on virtual patients generalize to held-out real patients. Our results highlight the effectiveness in utilizing informative immune feature interdependencies for classification tasks and suggest broad impacts of ML applications for personalized vaccination strategies among high-risk populations.

Indexed as

adaptive immunityantiretroviral therapyARTbiomarker classificationHIVimmune dysregulationimmunologymachine learningMLpersonalized vaccination strategiesrandom forestsRFsSARS-CoV-2 vaccinationsynthetic dataTh1 imprintingvaccinology

Identifiers

PMID42028410
PMCPMC13100683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.